INS and Insulin resistance: A hallmark risk factor of MetS is insulin resistance (IR) [16], which is an impairment of insulin function to promote glucose uptake in insulin-sensitive target tissues, such as skeletal muscle and adipose tissue [17], resulting in abnormal glucose homeostasis [16].